Sirtuin-3 (SIRT3) expression is associated with overall survival in esophageal cancer

Annals of Diagnostic Pathology

Volumn 17, Issue 6, 2013, Pages 483-485

  Zhao, Yue ^a   Yang, Huichai ^a   Wang, Xiaoling ^a   Zhang, Ruixing ^a   Wang, Cuiju ^a   Guo, Zhanjun ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Esophageal cancer; Predictor; SIRT3; Survival

Indexed keywords

SIRTUIN 3; SIRT3 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; CANCER SURVIVAL; ESOPHAGUS CANCER; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FOLLOW UP; GENE EXPRESSION REGULATION; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; TREATMENT OUTCOME;

CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SIRTUIN 3; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84887998512     PISSN: 10929134     EISSN: 15328198     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2013.06.001     Document Type: Article

References (25)

1. W.J. Blot, and J.Y. Li Some considerations in the design of a nutrition intervention trial in Linxian, People's Republic of China Natl Cancer Inst Monogr 69 1985 29 34
2. C.C. Abnet, K. Huppi, and A. Carrera Control region mutations and the 'common deletion' are frequent in the mitochondrial DNA of patients with esophageal squamous cell carcinoma BMC Cancer 4 2004 30
3. P. Blanchard, L. Quero, and C. Hennequin Prognostic and predictive factor of oesophageal carcinoma Bull Cancer 96 2009 379 389
4. L.W. Finley, A. Carracedo, and J. Lee SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization Cancer Cell 19 2011 416 428
5. T. Finkel, C.X. Deng, and R. Mostoslavsky Recent progress in the biology and physiology of sirtuins Nature 460 2009 587 591
6. T.Y. Alhazzazi, P. Kamarajan, and E. Verdin SIRT3 and cancer: tumor promoter or suppressor? Biochim Biophys Acta 2011 1816 80 88
7. E. Verdin, M.D. Hirschey, and L.W. Finley Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling Trends Biochem Sci 35 2010 669 675
8. X. Qiu, K. Brown, and M.D. Hirschey Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation Cell Metab 12 2010 662 667
9. R. Tao, M.C. Coleman, and J.D. Pennington Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress Mol Cell 40 2010 893 904
10. C. Schlicker, M. Gertz, and P. Papatheodorou Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5 J Mol Biol 382 2008 790 801
11. E. Bartnik, A. Lorenc, and K. Mroczek Human mitochondria in health, disease, ageing and cancer J Appl Genet 42 2001 65 71
12. L. Galluzzi, O. Kepp, and C. Trojel-Hansen Mitochondrial control of cellular life, stress, and death Circ Res 111 2012 1198 1207
13. Y. Tsujimoto Apoptosis and necrosis: intracellular ATP levels as a determinant for cell death model Cell Death Differ 4 1997 429 434
14. H.S. Kim, K. Patel, and K. Muldoon-Jacobs SIRT3 is a mitochondria- localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress Cancer Cell 17 2010 41 52
15. N. Ashraf, S. Zino, and A. Macintyre Altered sirtuin expression is associated with node-positive breast cancer Br J Cancer 95 2006 1056 1061
16. S. Li, M. Banck, and S. Mujtaba p53-induced growth arrest is regulated by the mitochondrial SirT3 deacetylase PLoS One 5 2010 e10486
17. T.Y. Alhazzazi 2nd, P. Kamarajan, and N. Joo Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer Cancer 117 2011 1670 1678
18. Z. Guo, C. Wu, X. Wang, and C. Wang A polymorphism at the miR-502 binding site in the 3'-untranslated region of the histone methyltransferase SET8 is associated with hepatocellular carcinoma outcome Int J Cancer 131 2012 1318 1322
19. W.M. Merritt, Y.G. Lin, and L.Y. Han Dicer, Drosha, and outcomes in patients with ovarian cancer N Engl J Med 359 2008 2641 2650
20. N.R. Sundaresan, S.A. Samant, and V.B. Pillai SIRT3 is a stress-responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku70 Mol Cell Biol 28 2008 6384 6401
21. N.R. Sundaresan, M. Gupta, and G. Kim Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice J Clin Invest 119 2009 2758 2771
22. H. Yang, T. Yang, and J.A. Baur Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival Cell 130 2007 1095 1107
23. S.J. Allison, and J. Milner SIRT3 is pro-apoptotic and participates in distinct basal apoptotic pathways Cell Cycle 6 2007 2669 2677
24. G. Marfe, M. Tafani, and M. Indelicato Kaempferol induces apoptosis in two different cell lines via Akt inactivation, Bax and SIRT3 activation, and mitochondrial dysfunction J Cell Biochem 106 2009 643 650
25. E.L. Bell, B.M. Emerling, and S.J. Ricoult SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production Oncogene 30 2011 2986 2996